Welcome to our dedicated page for Walgreens Boots Alliance news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreens Boots Alliance stock.
Walgreens Boots Alliance, Inc. became a privately owned company after Sycamore Partners completed its acquisition of WBA in August 2025. News about the former public issuer centers on the transition of Walgreens and related businesses under private ownership, including Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD.
Recurring company updates also cover Walgreens' U.S. retail pharmacy and health-services operations, specialty pharmacy limited-distribution drug relationships, and capital actions tied to WBA and Walgreen Co. senior notes, including tender offers and consent solicitations.
Walgreens Boots Alliance (WBA) announced its full acquisition of Shields Health Solutions for approximately $1.37 billion, completing a strategic move to strengthen its specialty pharmacy segment. This follows WBA's previous increase in stake to about 70% in September 2021. Shields has demonstrated robust growth with a 57% sales increase in the first nine months of fiscal 2022, enhancing WBA’s consumer-centric healthcare strategy. Additionally, WBA has restructured its U.S. leadership with changes to its pharmacy and retail divisions.
Walgreens announces participation in the inaugural cohort of 51 Labs, an accelerator dedicated to advancing women+’s health, particularly during menopause. The program, launched by MATTER, partners with Astellas Pharma US, Parkview Health, and the University of Chicago Medicine. It aims to foster healthcare solutions for the 1.3 million U.S. women entering menopause annually, addressing a historically underserved health segment. The cohort will focus on enhancing awareness and managing symptoms to improve overall health outcomes for women+ during this transition.
Walgreens Boots Alliance (WBA) will release its fourth quarter and fiscal 2022 earnings results on Oct. 13, 2022, at 7 a.m. Eastern time. The management will host a two-hour conference call starting at 8:30 a.m. Eastern time, which will be available via the WBA investor relations website. The replay will be accessible for a week post-call. With approximately 13,000 locations globally and over 315,000 employees, WBA continues to innovate in retail pharmacy and healthcare services, emphasizing well-being and community health.
Walgreens Boots Alliance (Nasdaq: WBA) has appointed Inderpal Bhandari to its board and Hsiao Wang as CIO, enhancing its leadership with expertise in IT for healthcare and retail. A new Finance and Technology Committee has been formed to focus on strategic growth in technology. Bhandari, previously IBM's global chief data officer, brings extensive IT experience, while Wang, an MIT graduate, previously led technology for The Michaels Company and Walmart. This leadership expansion aims to accelerate WBA's healthcare platform and improve customer experiences.
Walgreens has begun offering updated COVID-19 boosters from Pfizer and Moderna for individuals aged 12 and older, authorized by the FDA and CDC. These boosters target the Omicron variants BA.4 and BA.5, prevalent in the U.S. Appointments can be scheduled via the Walgreens app or online. Eligible individuals must have completed a primary vaccine series or received a booster at least 2 months prior. Additionally, Walgreens encourages simultaneous flu vaccinations to enhance community protection. Walgreens has administered nearly 70 million COVID-19 vaccines since the pandemic began.
Walgreens Boots Alliance (WBA) has completed a majority share acquisition of CareCentrix, investing $330 million for 55% ownership, valuing the company at $800 million. This strategic move enhances Walgreens Health's capabilities in home care, allowing better management of patients transitioning from hospitals. CareCentrix manages care for 19 million members across 7,400 providers, achieving a 20% reduction in total care costs. The partnership aims to improve healthcare delivery, reduce hospital readmissions, and enhance overall patient outcomes.
Summary not available.
Walgreens Boots Alliance (WBA) has sold 11 million shares of Option Care Health (OPCH) in a secondary offering, reducing its ownership from 20.5% to 14.4%. The proceeds will primarily be utilized for debt paydown and to support strategic priorities. CEO Rosalind Brewer emphasized the action aligns with the company's strategy and enhances balance sheet flexibility. Walgreens Boots Alliance continues to serve millions through over 13,000 locations worldwide, aiming to improve healthcare access.
Walgreens is offering cash rewards for vaccinations, including a $5 reward from August to December and a $10 reward in September for anyone receiving vaccines at its nearly 9,000 locations. This initiative aims to combat rising flu cases, observed as flu activity in the Southern Hemisphere points to possible increases in the U.S. during the 2022-2023 season. Vaccination appointments are encouraged, allowing for co-administration of various vaccines. Additionally, Walgreens continues its 'Get a Shot. Give a Shot.' program to provide immunizations to children globally.
This August, Huggies and Walgreens are partnering for the sixth consecutive year to address diaper need in the U.S. For every pack of Huggies Diapers purchased, one day's worth of diapers will be donated to the National Diaper Bank Network, with a goal of donating up to 1 million diapers. Diaper need affects one in three families in the U.S., impacting children's health and wellbeing. Since 2011, this collaboration has provided over 300 million diapers to families in need. The initiative emphasizes the importance of access to clean diapers for children's health.